Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet’s disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protoc... by Sander W Tas, Joost Raaphorst, Paco M J Welsing, Jacob M van Laar, Rogier M Thurlings, Robbert J Goekoop, César Magro Checa, Jan A M van Laar, Bettina C Geertsema-Hoeve, Nicolle H Rekers, Erik Present

Get full text

OptimisAtion of Diagnostic Accuracy in idioPathic inflammaTory myopathies (ADAPT study): a protocol for a prospective diagnostic accuracy study of multimodality testing in patients... by Frank F Smithuis, Anneke J van der Kooi, Joost Raaphorst, Ivo N van Schaik, Marianne de Visser, Paul A Baars, Patrick M M Bossuyt, Eleonora Aronica, Johannes H T M Koelman, Camiel Verhamme, Hannah A W Walter, Renske G Kamperman, Wouter V Potters, Ester M M van Leeuwen

Get full text